A single dose of the DENV-1 candidate vaccine rDEN1Δ30 is strongly immunogenic and induces resistance to a second dose in a randomized trial. by Anna P Durbin, Stephen S Whitehead, Donna Shaffer, Dan Elwood, Kimberli Wanionek, Bhavin Thumar, Joseph E Blaney, Brian R Murphy, Alexander C Schmidt

Connect to this object online.

Data-driven epidemiologic approach to conducting site feasibility for a global phase III tuberculosis vaccine clinical trial by Wai-Ling Mui, Falgunee K. Parekh, Ashley S. Tseng, Joy Toro, Taylor Craig, Maggwa Ndugga, Alexander C. Schmidt, Alemnew F. Dagnew, Craig Penz, Ghiorghis Belai

Connect to this object online.

Data-driven epidemiologic approach to conducting site feasibility for a global phase III tuberculosis vaccine clinical trial. by Wai-Ling Mui, Falgunee K Parekh, Ashley S Tseng, Joy Toro, Taylor Craig, Maggwa Ndugga, Alexander C Schmidt, Alemnew F Dagnew, Craig Penz, Ghiorghis Belai

Connect to this object online.

Dengue illness index-A tool to characterize the subjective dengue illness experience. by Stephen J Thomas, Liane Agulto, Kim Hendrickx, Martin Erpicum, Kay M Tomashek, M Cristina Cassetti, Catherine Laughlin, Alexander Precioso, Alexander C Schmidt, Federico Narvaez, João Bosco Siqueira, Hasitha Tissera, Robert Edelman

Connect to this object online.

Development of standard clinical endpoints for use in dengue interventional trials. by Kay M Tomashek, Bridget Wills, Lucy Chai See Lum, Laurent Thomas, Anna Durbin, Yee-Sin Leo, Norma de Bosch, Elsa Rojas, Kim Hendrickx, Martin Erpicum, Liane Agulto, Thomas Jaenisch, Hasitha Tissera, Piyarat Suntarattiwong, Beth Ann Collers, Derek Wallace, Alexander C Schmidt, Alexander Precioso, Federico Narvaez, Stephen J Thomas, Robert Edelman, João Bosco Siqueira, M Cristina Cassetti, Walla Dempsey, Duane J Gubler

Connect to this object online.